Our Approach to Clinical Development
Our clinical development approach focuses on matching our drug mechanism to patient biology and using relevant outcome metrics that keep patient benefit a top priority.
![Match-MOA-to-patient-biology](/images/icons/Match-MOA-to-patient-biology.png)
Match MOA to patient biology
The mechanism of action of our drug should match the underlying biology of the patient population we aim to treat.
![Use-relevant-metrics](/images/icons/Use-relevant-metrics.png)
Use relevant metrics
Clinical trial outcomes should directly measure the expected benefits of our drug on patients.
![anchored](/images/icons/anchored.png)
Progressive but anchored trial design
Our clinical trial design should utilize modern, progressive techniques but remain anchored to outcomes that matter to patients.
![patient-benefit](/images/icons/patient-benefit.png)
Focus on patient benefit
We prioritize what is best for patients in our clinical development approach.
Latest News